BNP Paribas Financial Markets’s Cardiovascular Systems, Inc. CSII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-18,951
| Closed | -$376K | – | 4072 |
|
|
2023
Q1 | $376K | Sell |
18,951
-31,120
| -62% | -$537K | ﹤0.01% | 2886 |
|
|
2022
Q4 | $682K | Sell |
50,071
-98,258
| -66% | -$1.37M | ﹤0.01% | 2397 |
|
|
2022
Q3 | $2.06M | Sell |
148,329
-37,788
| -20% | -$561K | ﹤0.01% | 1942 |
|
|
2022
Q2 | $2.67M | Buy |
186,117
+2,507
| +1% | +$43.5K | ﹤0.01% | 1584 |
|
|
2022
Q1 | $4.15M | Buy |
183,610
+12,382
| +7% | +$240K | 0.01% | 1409 |
|
|
2021
Q4 | $3.22M | Buy |
171,228
+132,716
| +345% | +$3.54M | ﹤0.01% | 1671 |
|
|
2021
Q3 | $1.26M | Buy |
38,512
+24,383
| +173% | +$910K | ﹤0.01% | 2222 |
|
|
2021
Q2 | $603K | Buy |
14,129
+6,317
| +81% | +$247K | ﹤0.01% | 2438 |
|
|
2021
Q1 | $300K | Sell |
7,812
-669
| -8% | -$28.5K | ﹤0.01% | 2848 |
|
|
2020
Q4 | $371K | Sell |
8,481
-1,818
| -18% | -$68.4K | ﹤0.01% | 2604 |
|
|
2020
Q3 | $405K | Buy |
10,299
+7,733
| +301% | +$250K | ﹤0.01% | 2349 |
|
|
2020
Q2 | $81K | Sell |
2,566
-12,029
| -82% | -$449K | ﹤0.01% | 2856 |
|
|
2020
Q1 | $514K | Buy |
14,595
+5,721
| +64% | +$241K | ﹤0.01% | 2329 |
|
|
2019
Q4 | $431K | Buy |
8,874
+2,554
| +40% | +$116K | ﹤0.01% | 2541 |
|
|
2019
Q3 | $300K | Buy |
6,320
+1,637
| +35% | +$76.9K | ﹤0.01% | 2515 |
|
|
2019
Q2 | $201K | Sell |
4,683
-3,098
| -40% | -$120K | ﹤0.01% | 2619 |
|
|
2019
Q1 | $301K | Buy |
7,781
+7,040
| +950% | +$239K | ﹤0.01% | 2446 |
|
|
2018
Q4 | $21.1K | Sell |
741
-1,123
| -60% | -$35.7K | ﹤0.01% | 3094 |
|
|
2018
Q3 | $73K | Sell |
1,864
-118
| -6% | -$4.36K | ﹤0.01% | 2903 |
|
|
2018
Q2 | $64.1K | Sell |
1,982
-5,846
| -75% | -$161K | ﹤0.01% | 3008 |
|
|
2018
Q1 | $172K | Sell |
7,828
-362
| -4% | -$8.7K | ﹤0.01% | 2884 |
|
|
2017
Q4 | $194K | Buy |
8,190
+3,667
| +81% | +$92.4K | ﹤0.01% | 2976 |
|
|
2017
Q3 | $127K | Sell |
4,523
-612
| -12% | -$18.6K | ﹤0.01% | 2668 |
|
|
2017
Q2 | $166K | Buy |
5,135
+3,165
| +161% | +$96.5K | ﹤0.01% | 2557 |
|
|
2017
Q1 | $55.7K | Sell |
1,970
-3,767
| -66% | -$100K | ﹤0.01% | 2699 |
|
|
2016
Q4 | $139K | Buy |
5,737
+292
| +5% | +$7.17K | ﹤0.01% | 2392 |
|
|
2016
Q3 | $129K | Buy |
5,445
+1,540
| +39% | +$33.7K | ﹤0.01% | 1980 |
|
|
2016
Q2 | $71.8K | Buy |
3,905
+941
| +32% | +$14.7K | ﹤0.01% | 2213 |
|
|
2016
Q1 | $30.7K | Sell |
2,964
-1,656
| -36% | -$16.8K | ﹤0.01% | 2103 |
|
|
2015
Q4 | $69.9K | Sell |
4,620
-2,028
| -31% | -$30.1K | ﹤0.01% | 2108 |
|
|
2015
Q3 | $105K | Buy |
6,648
+3,867
| +139% | +$97.5K | ﹤0.01% | 2358 |
|
|
2015
Q2 | $73.6K | Buy |
2,781
+2,122
| +322% | +$68.5K | ﹤0.01% | 2263 |
|
|
2015
Q1 | $25.7K | Buy |
+659
| New | +$22.7K | ﹤0.01% | 2248 |
|
|
2014
Q4 | – | Sell |
-1,680
| Closed | -$39.7K | – | 3401 |
|
|
2014
Q3 | $39.7K | Buy |
1,680
+1,624
| +2,900% | +$46.2K | ﹤0.01% | 2725 |
|
|
2014
Q2 | $1.75K | Buy |
+56
| New | +$1.61K | ﹤0.01% | 3189 |
|
|
2014
Q1 | – | Sell |
-312
| Closed | -$10.7K | – | 3900 |
|
|
2013
Q4 | $10.7K | Buy |
+312
| New | +$9.08K | ﹤0.01% | 2601 |
|
Other funds holding CSII
BNP Paribas Financial Markets's CSII Position: Q2 2023 in Review
BNP Paribas Financial Markets sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 18,951 shares — an estimated $376K sold.
BNP Paribas Financial Markets first reported a position in CSII in Q4 2013 and held it in 36 quarters. The position peaked at $4.15M in Q1 2022. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.
- BNP Paribas Financial Markets reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
- BNP Paribas Financial Markets sold 18,951 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $376K.
- BNP Paribas Financial Markets first reported a position in Cardiovascular Systems, Inc. in Q4 2013 and held it in 36 quarters.
- BNP Paribas Financial Markets's Cardiovascular Systems, Inc. position peaked at $4.15M in Q1 2022.
- 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2023, filed 9 Aug 2023.